• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑膜炎球菌病:这场战斗胜利了吗?

Meningococcal disease: has the battle been won?

作者信息

Millar Beverley C, Moore P J A, Moore J E

机构信息

Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, UK.

School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.

出版信息

J R Army Med Corps. 2017 Aug;163(4):235-241. doi: 10.1136/jramc-2016-000695. Epub 2016 Dec 30.

DOI:10.1136/jramc-2016-000695
PMID:28039342
Abstract

Meningococcal disease is a worldwide life-threatening infection associated in many cases with debilitating long-term sequelae, both within the military and civilian populations. Military recruits are at a higher risk of acquiring this infection due to numerous factors, such as young recruits in the age group 18-25 years, high carriage rates of meningococci, communal and crowed living quarters and global deployment or training in regions with different meningococcal serogroup epidemiology. Although these increased risk factors among young recruits remain, the increased incidence of disease is now historic. Numerous outbreaks have been reported among military personnel, however although the incidence of the disease continues to decrease, there are still sporadic cases. The non-specific symptoms, sudden onset and rapid progression of the infection results in a limited time frame to both diagnose and successfully treat the patient. Many developments have been made in relation to the microbiological diagnosis of the disease, particularly in the era of molecular diagnostics, which have the potential to diagnose the infection more quickly. Developments in vaccinology, and in particular with relation to biotechnology and reverse vaccinology, have led to the availability of new meningococcal vaccines, further enabling disease prevention. This paper outlines the history of meningococcal disease in relation to the military and highlights the new developments in both diagnostics and vaccination, which have the potential to diagnose, treat and control meningococcal disease in a more efficient manner.

摘要

脑膜炎球菌病是一种全球范围内危及生命的感染病,在许多情况下,无论在军队还是平民中,都会伴有使人虚弱的长期后遗症。由于多种因素,新兵感染这种疾病的风险更高,比如年龄在18至25岁的年轻新兵、脑膜炎球菌的高携带率、集体且拥挤的居住环境以及在不同脑膜炎球菌血清群流行病学地区的全球部署或训练。尽管年轻新兵中这些增加的风险因素依然存在,但疾病发病率上升如今已成为历史。军队人员中已报告了多起疫情,然而,尽管该病发病率持续下降,但仍有散发病例。感染的非特异性症状、突然发作和快速进展导致诊断和成功治疗患者的时间有限。在该病的微生物学诊断方面已取得许多进展,特别是在分子诊断时代,这有可能更快地诊断感染。疫苗学的发展,尤其是与生物技术和反向疫苗学相关的发展,已带来新的脑膜炎球菌疫苗,进一步实现了疾病预防。本文概述了与军队相关的脑膜炎球菌病历史,并强调了诊断和疫苗接种方面的新进展,这些进展有可能更有效地诊断、治疗和控制脑膜炎球菌病。

相似文献

1
Meningococcal disease: has the battle been won?脑膜炎球菌病:这场战斗胜利了吗?
J R Army Med Corps. 2017 Aug;163(4):235-241. doi: 10.1136/jramc-2016-000695. Epub 2016 Dec 30.
2
Invasive meningococcal disease and travel.侵袭性脑膜炎球菌病与旅行。
J Infect Public Health. 2010 Dec;3(4):143-51. doi: 10.1016/j.jiph.2010.09.008. Epub 2010 Nov 11.
3
Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.1964年至1998年美国军人中与不同血清群特异性成分疫苗常规使用相关的脑膜炎球菌病
Clin Infect Dis. 2002 Dec 1;35(11):1376-81. doi: 10.1086/344273. Epub 2002 Nov 5.
4
Effectiveness of the meningococcal vaccination programme for British Armed Forces recruits.英国武装部队新兵脑膜炎球菌疫苗接种计划的有效性。
Commun Dis Public Health. 2000 Dec;3(4):298-9.
5
Vaccination campaign against meningococcal disease in army recruits in Italy.意大利军队新兵预防脑膜炎球菌病的疫苗接种运动。
Epidemiol Infect. 1990 Dec;105(3):579-83. doi: 10.1017/s0950268800048214.
6
Preventive effect of meningococcal vaccination in Israeli military recruits.脑膜炎球菌疫苗接种对以色列新兵的预防效果。
Am J Infect Control. 2010 Feb;38(1):56-8. doi: 10.1016/j.ajic.2009.04.290. Epub 2009 Aug 25.
7
Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges.以色列国防军中的脑膜炎球菌病:流行病学趋势与新挑战。
Isr J Med Sci. 1995 Jan;31(1):54-8.
8
Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease.B群脑膜炎球菌疫苗Bexsero(®)的临床经验:减轻B群脑膜炎球菌疾病负担的前景
Vaccine. 2016 Feb 10;34(7):875-80. doi: 10.1016/j.vaccine.2015.11.057. Epub 2015 Dec 10.
9
Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines.脑膜炎球菌病暴发的预防与控制:B 群脑膜炎球菌疫苗的新作用
Vaccine. 2015 Jul 17;33(31):3628-35. doi: 10.1016/j.vaccine.2015.06.046. Epub 2015 Jun 17.
10
Meningococcal disease and college students. Recommendations of the Advisory Committee on Immunization Practices (ACIP).脑膜炎球菌病与大学生。免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2000 Jun 30;49(RR-7):13-20.

引用本文的文献

1
A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.抗击传染病的军事医学策略历史回顾:从战场到全球健康
Biomedicines. 2022 Aug 22;10(8):2050. doi: 10.3390/biomedicines10082050.
2
Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context.群体性集会:印度背景下脑膜炎球菌疫苗接种范围的评估。
Hum Vaccin Immunother. 2021 Jul 3;17(7):2216-2224. doi: 10.1080/21645515.2020.1871572. Epub 2021 Feb 19.
3
Retrospective analysis of the etiology, clinical characteristics and outcomes of community-acquired bacterial meningitis in the University Infectious Diseases Centre in Lithuania.
立陶宛大学传染病中心获得性细菌性脑膜炎的病因、临床特征和结局的回顾性分析。
BMC Infect Dis. 2020 Oct 7;20(1):733. doi: 10.1186/s12879-020-05462-0.
4
Evaluation of Carriage with the Analysis of Serogroups, Genogroups and Clonal Complexes among Polish Soldiers.波兰士兵中携带情况的血清群、基因群和克隆复合体分析评估
Pol J Microbiol. 2018;67(4):493-500. doi: 10.21307/pjm-2018-058.
5
Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.免疫力减弱与微生物疫苗——美国国立过敏与传染病研究所研讨会
Clin Vaccine Immunol. 2017 Jul 5;24(7). doi: 10.1128/CVI.00034-17. Print 2017 Jul.